Functional Defects of NHL Patients’ T-Cells after Different Chemotherapy Regimens Activated By CD19/CD3 Tetravalent Bispecific TandAb® AFM11
Düll et al.
ASH 2016 – AFM11
Düll et al.
ASH 2016 – AFM11
Pahl et al.
ASH 2016 – AFM13
Reusch et al.
Clin Cancer Res. 2016 Dec 1; 22(23):5829-5838. Epub 2016 May 17.
Ellwanger et al.
AACR 2016
Ellwanger et al.
AACR 2016
Rothe et al.
Blood. 2015. Jun 25; 125(26): 4024-31. doi: 10.1182/ blood-2014-12-614636. Epub 2015 Apr 17./.
Hutchings M.
Blood. 2015 Jun 25; 125(26): 3967-8.doi: 10.1182/ blood-2015-05-641712./.
Ellwanger et al.
CIMT 2015
Reusch et al.
MAbs. 2015 May 4; 7(3):584-604. doi: 10.1080/19420862.2015.1029216. [PubMed - in process].
Eissenberg et al.
ASCO 2015